CYTO — Cytophage Technologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapSucker Stock

Annual balance sheet for Cytophage Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash
Cash and Short Term Investments	4.84	2.25	0.032
Net Total Accounts Receivable
Net Total Receivables	0.095	0.456	0.345
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4.96	2.75	2.95
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.872	0.935	2.49
Total Assets	5.83	3.69	5.44
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.173	0.238	3.64
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	0.281	0.238	5.07
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	5.55	3.45	0.373
Total Liabilities & Shareholders' Equity	5.83	3.69	5.44
Total Common Shares Outstanding